Skip to content

A comparative study of the effects of dexmedetomidine and sufentanil combined with ropivacaine on the delivery of epidural analgesia

A comparative study of the effects of dexmedetomidine and sufentanil combined with ropivacaine on the delivery of epidural analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038702
Enrollment
Unknown
Registered
2020-09-29
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor analgesia

Interventions

A:10 ml 0.5 ug / ml dexmedetomidine combined with 0.1% ropivacaine
B:10ml 0.5 ug / ml sufentanil combined with 0.1% ropivacaine

Sponsors

Chengdu Women's and Children's Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.1 aged >=18 years old; 1.2 primiparas with single full-term pregnancy (gestational weeks >=37W), vaginal delivery and labor analgesia requirements; 1.3 American Society of anesthesiologists (ASA) grade I ~ II; 1.4 the subjects participated voluntarily and informed consent was signed

Exclusion criteria

Exclusion criteria: 2.1 patients with severe heart, lung, liver, kidney and other organ diseases, hemorrhagic diseases or other system diseases; 2.2 patients with contraindications to epidural analgesia or allergic to local anesthetics to be used; 2.3 the body temperature was higher than 37.5 degree C before analgesia; 2.4 patients with cervical dilatation > 3 cm, non cephalic pregnancy, cesarean section and induced labor; 2.5 known genetic or congenital fetal malformations, fetal growth restriction or oligohydramnios possibly related to placental dysfunction; 2.6 patients with malignant tumor or severe preeclampsia; 2.7 patients with history of cesarean section, lower abdominal surgery or urinary surgery; 2.8 spinal deformity or previous spinal surgery; 2.9 patients with sedative or long-term use of sedative drugs; 2.10 patients with mental history; 2.11 those who are considered unsuitable to participate in the clinical study by the competent physician

Design outcomes

Primary

MeasureTime frame
Pain score;blood pressure;Body temperature, blood pressure, heart rate, mean arterial pressure, VAS score, Ramsay Sedation Scale score and motor nerve block level;The time of analgesic initiation, the first labor process, the second labor process and the total labor process time;Whether there is bleeding during labor and the amount of bleeding, the amount of bleeding in 2 hours and 24 hours after delivery;Total use of analgesics;

Secondary

MeasureTime frame
Sex of newborn;Birth weight of newborn;Apgar score at 1 and 5 min after delivery;NBNA in 3-day-old neonates;

Countries

China

Contacts

Public ContactFan Mei

Chengdu Women's and Children's Central Hospital

6715632@qq.com+86 15882326791

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026